A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...

One of the classes of medications ­­– glucagon-like peptide-1 receptor agonists (GLP-1) – treats Type 2 diabetes by stimulating insulin release by the pancreas, delaying gastric emptying ...

New research presented at the ACG Annual Meeting suggests that GLP-1RAs lower the risk of pancreatic cancer in patients with ...

GLP-1 drugs, including popular names like Ozempic and Wegovy, which were initially prescribed for managing diabetes, are now widely used for weight loss. The demand for these drugs has grown ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...

(NewMediaWire) - November 11, 2024 - DALLAS GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the ...